Search Results - "Zhang, Arianna J."

Expert consensus achieved on a working core outcome set for cutaneous lupus erythematosus research in survey following the 5th International Conference on Cutaneous Lupus Erythematosus (ICCLE) by Zhang, Arianna J, Perez-Chada, Lourdes M, Werth, Victoria P, Merola, Joseph F

“…Subsequently, they recommended candidate outcome measures for each core domain based on review of the literature (table 1).3 The proposed COS (ie, core domain…”
Get full text

Debate at the GRAPPA 2023 Annual Meeting: Should Methotrexate Be the First Systemic Therapy in Psoriatic Disease? by Zhang, Arianna J, Merola, Joseph F, Tillett, William

“…Despite substantial evidence that methotrexate (MTX) has inferior efficacy, safety, and tolerability compared to newer systemic therapies, MTX remains one of…”
Get full text

BRCA1‐associated protein (BAP1)‐inactivated melanocytic tumors by Zhang, Arianna J., Rush, Patrick S., Tsao, Hensin, Duncan, Lyn M.

“…Although discussed using variable terminology, cutaneous BRCA1‐associated protein (BAP1)‐inactivated melanocytic tumor (BIMT) has been considered a discrete…”
Get full text

GRAPPA 2023 Annual Meeting Report: Hot Topic Session on Measurement of Musculoskeletal Symptoms in Psoriatic Disease by Zhang, Arianna J, Perez-Chada, Lourdes M, Strand, Vibeke, Armstrong, April W, Gottlieb, Alice B, Merola, Joseph F

“…During the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2023 annual meeting, the International Dermatology Outcome Measures…”
Get full text

Report of the IDEOM Meeting Adjacent to the GRAPPA 2023 Annual Meeting by Ball, Gretchen D, Yee, Danielle, Zhang, Arianna J, Perez-Chada, Lourdes M, Strand, Vibeke, Merola, Joseph F, Armstrong, April W, Gottlieb, Alice B

“…The nonprofit organization International Dermatology Outcome Measures (IDEOM) is committed to improving the implementation of patient-centered outcome measures…”
Get full text